Oregon Prescription Drug Monitoring Program

Opioid Abuse Prevention Headlines OMA Priorities

CEO Bryan Boehringer is working with a statewide coalition to reduce opioid abuse, while Rep. Knute Buehler is introducing legislation next month.

There’s never been a more challenging time to deal with opioid abuse since Oregon leads the nation in nonmedical use of these morphine-based drugs.

Privacy Concerns Force Prescription Drug Monitoring Program Bill From Senate Floor

Sen. Alan Bates asked the Democratic leadership to pull his own bill modifying the prescription drug monitoring program after he discovered that SB 626 allowed county health officials and state epidemiologists to receive personally identifiable information.

The Senate was ready to pass a bill modifying the state’s controversial prescription drug monitoring program but Senate Majority Leader Diane Rosenbaum, D-Portland, pulled the bill unexpectedly after some Democrats objected to provisions that would have allowed public health officials to receive

House May Roll Back Bill Expanding Drug Monitoring Program

The Lund Report
Rep. Mitch Greenlick opposes allowing the Board of Pharmacy to add drugs to the tracking system that are not controlled by the DEA, aligning his concerns with the American Civil Liberties Union.

Editor's Note: This article has been amended for accuracy.

May 9, 2013 — Rep. Mitch Greenlick, D-Portland, has moved to scale back a measure that would enhance the Oregon Prescription Drug Monitoring Program, citing concerns raised by the American Civil Liberties Union.

Subscribe to Oregon Prescription Drug Monitoring Program